M.J. Pierik

Stevens, C. L., Adriaans, G. M. C., Spooren, C. E. G. M., Peters, V., Pierik, M. J., Weersma, R. K., van Dullemen, H. M., Festen, E. A. M., Visschedijk, M. C., Hendrix, E. M. B., Perenboom, C. W. M., Feskens, E. J. M., Dijkstra, G., Almeida, R. J., Jonkers, D. M. A. E., & Campmans-Kuijpers, M. J. E. (2025). Exploring diet categorizations and their influence on flare prediction in inflammatory bowel disease, using the Sparse Grouped Least Absolute Shrinkage and Selection Operator method. Clinical Nutrition, 47, 212-226. https://doi.org/10.1016/j.clnu.2025.02.027

van Linschoten, R. C. A., van Leeuwen, N., van Klaveren, D., Pierik, M. J., Creemers, R., Hendrix, E. M. B., Hazelzet, J. A., van der Woude, C. J., West, R. L., & van Noord, D. (2025). Prevalence, incidence, and mortality of inflammatory bowel disease in the Netherlands: development and external validation of machine learning models. Journal of Crohn's & Colitis, 19(2), Article jjaf017. https://doi.org/10.1093/ecco-jcc/jjaf017

Bevers, N., Aliu, A., Ardabili, A. R., Winken, B., Raijmakers, M., van de Vijver, E., Donker, A., Swinkels, D., Vreugdenhil, A., Pierik, M., & van Rheenen, P. (2025). Explorative study on the value of hepcidin in predicting iron non-responsiveness in paediatric inflammatory bowel disease. Pediatric Research, 97(3), 1096-1102. Article e28038. https://doi.org/10.1038/s41390-024-03375-1

Deben, D. S., Winkens, B., van Moorsel, S. A. W., van Oijen, B. P. C., Bus, P., Pierik, M. J., Simsek, M., de Boer, N. K. H., Leers, M. P. G., Wong, D. R., & van Bodegraven, A. A. (2024). Early therapeutic drug monitoring helps to identify inflammatory bowel disease patients with a high risk to fail thiopurine treatment. British Journal of Clinical Pharmacology, 90(12), 3296-3307. https://doi.org/10.1111/bcp.16219

Jans, A., Sinonquel, P., Seerden, T. C. J., De Bodelier, A., de Ridder, R., Pierik, M. J., Karstensen, J. G., Sloth, S., De Hertogh, G., Demedts, I., Willekens, H., Vermeire, S., & Bisschops, R. (2024). Dye-based chromoendoscopy versus i-scan virtual chromoendoscopy in long-standing ulcerative colitis: Multicenter prospective RCT. Endoscopy international open, 12(11), E1386-E1391. https://doi.org/10.1055/a-2443-1080

Demers, K., Bongers, B. C., van Kuijk, S. M. J., Plasqui, G., Jonkers, D. M. A. E., Pierik, M. J., & Stassen, L. P. S. (2024). Criterion Validity of Screening Tools and Field-Based Tests for Health-Related Physical Fitness in Inflammatory Bowel Disease. Digestive Diseases and Sciences, 69(11), 4072-4088. https://doi.org/10.1007/s10620-024-08682-5

Janssen, L., van Linschoten, R. C. A., West, R. L., Gilissen, L. P. L., Romberg-Camps, M., Brandts, L., Mujagic, Z., Romkens, T. E. H., & Pierik, M. (2024). Predicting mucosal inflammation in IBD patients using patient-reported symptom scores and a faecal calprotectin home test: protocol for a multicentre prospective validation study. BMJ Open, 14(10), Article e076290. https://doi.org/10.1136/bmjopen-2023-076290

Bak, M. T. J., Demers, K., Hammoudi, N., Allez, M., Silverberg, M. S., Fuhler, G. M., Parikh, K., Pierik, M. J., Stassen, L. P. S., van der Woude, C. J., Doukas, M., van Ruler, O., & de Vries, A. C. (2024). Systematic review: Patient-related, microbial, surgical, and histopathological risk factors for endoscopic post-operative recurrence in patients with Crohn's disease. Alimentary Pharmacology & Therapeutics, 60(3), 310-326. https://doi.org/10.1111/apt.18040

van Linschoten, R. C. A., Jansen, F. M., Pauwels, R. W. M., Smits, L. J. T., Atsma, F., Kievit, W., de Jong, D. J., de Vries, A. C., Boekema, P. J., West, R. L., Bodelier, A. G. L., Gisbertz, I. A. M., Wolfhagen, F. H. J., Römkens, T. E. H., Lutgens, M. W. M. D., van Bodegraven, A. A., Oldenburg, B., Pierik, M. J., Russel, M. G. V. M., ... LADI study group, the Dutch Initiative on Crohn, Colitis (ICC) (2024). A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial. Digestive diseases and sciences, 69(6), 2165-2174. https://doi.org/10.1007/s10620-024-08410-z

Aliu, A., Bosch, D. H. C. A., Keszthelyi, D., Ardabili, A. R., Colombel, J.-F., Sawyer, R., Törnblom, H., Hart, A., Jonkers, D. M. A. E., Pierik, M. J., & Mujagic, Z. (2024). Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD-Authors' reply. Alimentary Pharmacology & Therapeutics, 59(12), 1646-1647. https://doi.org/10.1111/apt.18031